Skip to main content
👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources. Claim this profile →
Dr Christopher Milross
Trust score 8/100 Accepting new patients

Dr

Dr Christopher Milross

Oncology

English
12,025+ Patients seen
13 Years in practice
11 Publications
1 Languages spoken

About

“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”

— Dr Christopher Milross

Education & training

  1. 2003–2009 MD · Medicine and Surgery
    Universitat de Barcelona
  2. 2009–2013 Residency · Oncology
    Universidad de Navarra

Career & appointments

  1. 2013-09–2014-08 Junior consultant
    Universitat de Barcelona Teaching Hospital — Oncology

Licenses & insurance

Medical licenses

— Organización Médica Colegial de España (OMC)
#-833607 active · expires 2028-12-31

Board certifications

European Board of Oncology
#EB-516F7A43 · issued 2014 · renewal 2024
Malpractice insurance: AmTrust Europe · 4,000,000 EUR coverage · No claims on file

Procedures performed

ProcedureCodeLifetime count
GP consultation 99213 2,135
Annual physical exam 99395 1,945
Vaccination administration 90471 57
Minor procedure (skin) 17110 670

Services & pricing

ServiceDurationModalityPrice
New patient consultation (60m) 60 min in_clinic|telemed 180.00 EUR
Follow-up consultation (30m) 30 min in_clinic|telemed|phone 90.00 EUR
Vaccination administration 90 min in_clinic 360.00 EUR
Minor procedure (skin) 60 min in_clinic 270.00 EUR

Office, team & in practice

Christopher Milross in consultation
IN OFFICE
Christopher Milross with the team
WITH TEAM
Christopher Milross at a conference
CONFERENCE

Videos

introduction · 132s
Meet Christopher Milross

Research & publications

h-index: 6 · i10: 8

  1. Long-term follow-up of Oncology across
    Christopher Milross, et al. · European Journal of Medicine, 2026
    DOI: 10.9202/euroclin.2026.0 · PMID: 36141957 · cited by 199
  2. Validation of clinical scoring in Oncology
    Christopher Milross, et al. · European Journal of Medicine, 2025
    DOI: 10.1534/euroclin.2025.1 · PMID: 30744746 · cited by 189

Invited talks

  • Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
  • Single-centre experience in Oncology National Society Meeting · · 2023 · oral abstract

Awards & memberships

Awards

  • 🏆 Top-rated Oncology — · EuroClinics Patient Choice · 2025 · regional

Society memberships

  • WONCA Europe — Family Doctors — Member · since 2014
  • national college of family doctors — Member · since 2014
  • European Union of Medical Specialists (UEMS) — Member · since 2014

Patient reviews

★ 0.00 0 verified reviews
Bedside Manner
0.05
Knowledge
0.08
Wait Time
3.80
Staff Friendliness
0.02
Ease Of Appointment
4.00
Value For Money
4.10
Would Recommend Pct
4
  • ★ 5 verified visit

    “Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”

    — Anna B. · 2026-05-23

  • ★ 5 verified visit

    “Took time to listen and reviewed all my previous results. I would absolutely recommend.”

    — Marco V. · 2026-04-10

  • ★ 4 verified visit

    “Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”

    — Helena F. · 2026-04-25

Articles by this doctor

  • Patient education Patient guide to Oncology
  • Awareness When should you see a oncology?

For international patients

Coordinator
Patient liaison · christopher.milross@euroclinics.example

Similar specialists

Browse all →